BCTXZ BRIACELL THERAPEUTICS CORP
Follow*W EXP 99/99/999 (warrant or right), issuer CIK 1610820
Filings received so far for Q3 2026: 4 13F filers report a position in BCTXZ shares at 2026-09-30. The quarter is not complete: its 13F deadline is 2026-11-14, and the counts grow as filings arrive.
13D and 13G filers
No 13D or 13G on this security in the data. Structured 13D/G data starts 2024-12-18.
Insider trades
No Form 4 transaction on this security in the data.
13F holders, Q3 2026
Filers in the available 13F reports with a share position at 2026-09-30, filer groups collapsed to one row (method), largest first. Options and principal amounts are left out. A group row states no % of portfolio, since each member reports its own portfolio: the members' percents are listed under it. A value about 1,000 times or 1/1,000 of the price other filers imply is shown as filed but neither ranks the row nor enters a sum.
| Holder | Shares | Value | % of portfolio | Change | Source |
|---|---|---|---|---|---|
| HEIGHTS CAPITAL MANAGEMENT, INCin group HEIGHTS CAPITAL MANAGEMENT, I… | 296,089 | $58.6K | 0.01% | -17,290 | 13F-HRTimelineGroup |
| SUSQUEHANNA INTERNATIONAL GROUP, LLPin group SUSQUEHANNA INTERNATIONAL GRO… | 287,547 | $56.9K | <0.01% | +173,025 | 13F-HRTimelineGroup |
| HRT FINANCIAL LP | 164,379 | $32K | <0.01% | +96,444 | 13F-HRTimeline |
| UBS Group AGin group UBS Group AG | 3,828 | $758 | <0.01% | new | 13F-HRTimelineGroup |